Protalix Biotherapeutics Inc (PLX)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Dror Bashan
Employees:
200
2 UNIVERSITY PLAZA, SUITE 100, HACKENSACK, NJ, 07601
201-696-9345
Are you looking for this stock instead?
Date | Ratio |
---|---|
2007-01-03 | 0.1 |
2019-12-20 | 1:10 |
Protalix BioTherapeutics, Inc. focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease. Its product pipeline comprises PRX-102, a therapeutic protein candidate, which is in the last stage of clinical trials.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|